Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy

Autor: Liam Chung, Kaitlyn Sadtler, Shoumyo Majumdar, Kenneth Estrellas, Jyothi Mula, Matthew T. Wolf, Lindsay A. Cheu, Kathryn R. Wagner, Jennifer H. Elisseeff
Rok vydání: 2018
Předmět:
0301 basic medicine
Duchenne muscular dystrophy
Myostatin
Muscle Development
Biochemistry
T-Lymphocytes
Regulatory

Myoblasts
Mice
0302 clinical medicine
Drug Delivery Systems
Absorbable Implants
Myocyte
Muscular dystrophy
Hyaluronic Acid
biology
Tissue Scaffolds
Chemistry
Antibodies
Monoclonal

Forkhead Transcription Factors
Hydrogels
Molecular Bases of Disease
musculoskeletal system
Cell biology
Extracellular Matrix
medicine.anatomical_structure
Mannose Receptor
Macrophage polarization
Receptors
Cell Surface

03 medical and health sciences
medicine
Animals
Humans
Regeneration
Lectins
C-Type

Muscle
Skeletal

Molecular Biology
Regeneration (biology)
Macrophages
Skeletal muscle
Cell Biology
Muscular Dystrophy
Animal

medicine.disease
Immunity
Innate

Transplantation
030104 developmental biology
Mannose-Binding Lectins
Gene Expression Regulation
biology.protein
Mice
Inbred mdx

030217 neurology & neurosurgery
Zdroj: The Journal of biological chemistry. 293(40)
ISSN: 1083-351X
Popis: Recent studies have reported that the immune system significantly mediates skeletal muscle repair and regeneration. Additionally, biological scaffolds have been shown to play a role in polarizing the immune microenvironment toward pro-myogenic outcomes. Moreover, myostatin inhibitors are known to promote muscle regeneration and ameliorate fibrosis in animal models of Duchenne muscular dystrophy (DMD), a human disease characterized by chronic muscle degeneration. Biological scaffolds and myostatin inhibition can potentially influence immune-mediated regeneration in the dystrophic environment, but have not been evaluated together. Toward this end, here we created an injectable biological scaffold composed of hyaluronic acid and processed skeletal muscle extracellular matrix. This material formed a cytocompatible hydrogel at physiological temperatures in vitro. When injected subfascially above the tibialis anterior muscles of both WT and dystrophic mdx-5(Cv) mice, a murine model of DMD, the hydrogel spreads across the entire muscle before completely degrading at 3 weeks in vivo. We found that the hydrogel is associated with CD206(+) pro-regenerative macrophage polarization and elevated anti-inflammatory cytokine expression in both WT and dystrophic mice. Co-injection of both hydrogel and myostatin inhibitor significantly increased FoxP3(+) regulatory T cell modulation and Foxp3 gene expression in the scaffold immune microenvironment. Finally, delivery of myostatin inhibitor with the hydrogel increased its bioactivity in vivo, and transplantation of immortalized human myoblasts with the hydrogel promoted their survival in vivo. This study identifies a key role for biological scaffolds and myostatin inhibitors in modulating a pro-regenerative immune microenvironment in dystrophic muscle.
Databáze: OpenAIRE